Concord Medical Files 2023 Annual Report on Form 20-F

Rhea-AI Summary

• English
• French
• German
• Italian
• Korean
• Spanish

Concord Medical Services Holdings (NYSE: CCM) filed its 2023 Annual Report on Form 20-F, showcasing its performance in cancer treatment, research, education, and prevention in China. Shareholders can access the report electronically or request a hard copy for free.

BEIJING, April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the Annual Report free of charge upon request. Requests should be submitted to http://ir.ccm.cn.

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China. For more information, please see http://ir.ccm.cn.

Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

View original content:https://www.prnewswire.com/news-releases/concord-medical-files-2023-annual-report-on-form-20-f-302122062.html

SOURCE Concord Medical Services Holdings Limited

FAQ

What type of company is Concord Medical Services Holdings ?

Concord Medical Services Holdings is a healthcare provider specialized in cancer treatment, research, education, and prevention in China.

When did Concord Medical file its 2023 Annual Report?

Concord Medical filed its 2023 Annual Report on Form 20-F for the fiscal year ended December 31, 2023.

Where can shareholders access Concord Medical's Annual Report electronically?

Shareholders can access Concord Medical's Annual Report electronically on the company's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov.

How can shareholders request a hard copy of Concord Medical's Annual Report?

Shareholders can request a hard copy of Concord Medical's Annual Report free of charge by submitting a request to http://ir.ccm.cn.